Apheresis as Therapy

Aferetica is an Innovative Small and Medium-sized Enterprise (SME), founded by Managers with tens of years of experience in Dialysis, Intensive Care, Cardiology and Medical Devices.

The company proposes itself as a catalyst for the creation of a Network of Clinicians, Academics, Researchers and Institutions, to create and validate New Apheretic Therapies, even for unexplored clinical areas.

An integrated and innovative vision of apheretic therapies is the challenge to face for a real evolution of the cure.

APHERESIS

Contribute to research for the development, creation and diffusion of complete apheretic therapies.

TRANSPLANTATION

For a concrete breakthrough in organ availability and transplantation outcome.

CRITICAL CARE

Apheresis as therapy: new frontiers in critically ill patients.

Our Therapeutic Systems

Products, knowledges, therapeutic protocols and clinical research.

PerLife tm
Persorb®
PerLungs
kawasumi
Aphercap
Cytosorb
Plasmapher Apherlung
Cardiosmart
abioSCOPE
Leucapher

Last updates

  • 4° WORKSHOP PURIFICATION THERAPIES

Save the Date WPT 2025

We’re very glad to announce the 4th Workshop Purification Therapies ‘From Research to Clinics: The End of the Beginning'

Events

  • Aferetica Congresso ACHBT 2024

ACHBT Congress

The 8th appointment of the PTJ 2024 is the ACHBT Congress - Association de Chirurgie Hépato-Bilio-Pancréatique et Transplantation, from March 28th to 29th at the Metropole Hotel, Lyon (France).

  • Aferetica : CKRT nel neonato e nel bambino critico 2024

CKRT in the newborn and critical child

Our 7th appointment of the Purification Therapies Journey 2024, the ECM Course ‘Continuous kidney replacement therapy (CKRT) in the newborn and critical child’, will be held from March 27th to 28th at the Bambino Gesù Pediatric Hospital (Rome).

  • Aferetica al 43° Congresso ISICEM

43rd ISICEM Congress

6th event of the Purification Therapies Journey 2024 is the 43rd ISICEM Congress - International Symposium on Intensive Care & Emergency Medicine